Manufacturers and industry officials attending the American Institute of Ultrasound Medicine’s 44th annual convention in April in San Francisco will get a chance to examine the emerging role of Doppler sonography in liver and kidney evaluation.
Manufacturers and industry officials attending the American Institute of Ultrasound Medicines 44th annual convention in April in San Francisco will get a chance to examine the emerging role of Doppler sonography in liver and kidney evaluation.
Color-flow Doppler has grown increasingly popular for gynecological applications, and physicians are beginning to adopt this form of ultrasound for the examination of stroke and head trauma patients (SCAN Ultrasound Market Report 2/00).
Attendees will get a better understanding of renal artery and vein scans, as well as those of the hepatic portal, hepatic venous system, and hepatic artery.
About 2500 people and 1000 manufacturers are expected to attend the AIUM convention April 1-5 at the Moscone Convention Center and San Francisco Marriott Hotel.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.